As we approach the respiratory vaccine season, conversations around the Respiratory Syncytial Virus (RSV) vaccine grow stronger. RSV, a virus causing cold-like symptoms, is particularly dangerous for infants, older adults, and those with underlying conditions. While most people recover in a week or two, RSV can become very serious for people with high risk. With the CDC’s new RSV recommendations, it’s crucial to stay informed. Heather Mercer, executive director of ImmunizeAR, provides patients and professionals in the healthcare community with the most accurate and up-to-date information on the RSV vaccine.
Download Free Tools and Resources

Sign up to receive our weekly newsletter and get all the latest news and updates, including the most recent episode of AFMC TV, right to your inbox!